Trial Profile
Tolerability, pharmacodynamics and preliminary efficacy of prasugrel in patients with sickle cell disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Dec 2011
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Embolism and thrombosis; Pain; Sickle cell anaemia
- Focus Adverse reactions
- 14 Dec 2011 New trial record
- 13 Dec 2011 Results presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology.